Review: taking Mucinex and Jakafi together


Summary

Drug interactions are reported among people who take Mucinex and Jakafi together. This review analyzes the effectiveness and drug interactions between Mucinex and Jakafi. It is created by eHealthMe based on reports of 37 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Mucinex

Mucinex has active ingredients of guaifenesin. It is often used in cough. (latest outcomes from Mucinex 9,449 users)

Jakafi

Jakafi has active ingredients of ruxolitinib phosphate. It is often used in primary myelofibrosis. (latest outcomes from Jakafi 8,093 users)

On Oct, 01, 2016

37 people who take Mucinex, Jakafi are studied.


Number of reports submitted per year:

Mucinex and Jakafi drug interactions.

Most common drug interactions over time *:

< 1 month:
  • lymphoma
1 - 6 months:
  • anaemia
  • contusion
  • disease progression
  • leukocytosis
  • pancytopenia
  • performance status decreased
  • thrombocytopenia
  • cardiac failure
  • depressed mood
  • drug ineffective
6 - 12 months:
  • abdominal pain
  • chills
  • colitis
  • confusional state
  • decreased appetite
  • dehydration
  • anaemia
  • asthenia
  • thrombocytopenia
  • urinary tract infection
1 - 2 years:
  • deep vein thrombosis
  • hypovolaemia
  • lung cancer metastatic
  • pneumonia
  • renal failure acute
2 - 5 years:
  • lymphoma
not specified:
  • fatigue
  • dyspnoea
  • pulmonary hypertension
  • splenomegaly
  • anaemia
  • pneumonia
  • abdominal pain
  • platelet count decreased
  • cardiac failure congestive
  • ecchymosis

Most common drug interactions by gender *:

female:
  • fatigue
  • platelet count decreased
  • abdominal pain
  • dyspnoea
  • pain in extremity
  • pneumonia
  • anaemia
  • cardiac failure
  • pulmonary hypertension
  • splenomegaly
male:
  • cardiac failure congestive
  • fatigue
  • pulmonary hypertension
  • rash
  • splenomegaly
  • anaemia
  • dyspnoea
  • cellulitis
  • decreased appetite
  • ecchymosis

Most common drug interactions by age *:

40-49:
  • abdominal distension
  • contusion
  • fluid retention
  • headache
  • hunger
  • joint swelling
  • pain in extremity
  • platelet count decreased
  • weight increased
50-59:
  • anxiety
  • depression
  • discomfort
  • dysstasia
  • fatigue
  • flatulence
  • haematocrit decreased
  • haemoglobin decreased
  • inflammation
  • pain
60+:
  • dyspnoea
  • pulmonary hypertension
  • fatigue
  • pneumonia
  • anaemia
  • splenomegaly
  • platelet count decreased
  • decreased appetite
  • cardiac failure congestive
  • cellulitis

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Mucinex and Jakafi?

Can you answer these questions?

More questions for: Mucinex, Jakafi

You may be interested in these reviews

More reviews for: Mucinex, Jakafi

On eHealthMe, Mucinex (guaifenesin) is often used to treat cough. Jakafi (ruxolitinib phosphate) is often used to treat primary myelofibrosis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.